Efficacy of panchakarma based ischemia reversal therapy along with diet modification in management of ischemic heart disease

Shital More-Mhaisane; Sadik Khan; Sachin Patil

doi:10.18203/2319-2003.ijbcp20243838

Authors

Shital More-Mhaisane Madhavbaug Cardiac Clinic, Morwadi Pimpri-Pune, Maharashtra, India
Sadik Khan Department of Medical Operations, Madhavbaug Cardiac Clinics and Hospitals, Thane, Maharashtra, India
Sachin Patil Department of Medical Operations, Madhavbaug Cardiac Clinics and Hospitals, Thane, Maharashtra, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20243838

Keywords:

Ayurveda, Duke treadmill test, Ischemia, Panchakarma

Abstract

Background: Aim was to evaluate the efficacy of panchakarma-based ischemia reversal therapy combined with diet modification in the management of ischemic heart disease.

Methods: A retrospective, single centre study was conducted at a Madhavbaug clinic in Maharashtra from February 2022 to December 2023. Patients aged 20-75 years diagnosed with ischemic heart disease were included in the study. Follow-up was conducted weekly, for total duration of 90 days. Day 1 and day 90 data were compared

Results: A total of 22 patients with mean age of 58.64±9.81 years were included in this study. VO_2max(day 1: 16.34±5.35 mL/kg/min and day 90: 28.11±7.39 mL/kg/min, p=0.00), duke treadmill score (day 1: -6.77±4.38 and day 90: 3.77±15.83, p=0.00), and MET value (day 1: 4.66±1.53 and day 90: 8.02±2.10, p=0.00) improved significantly at the 90-day follow-up.

Conclusions: Ischemia reversal therapy has proven to be effective in improving the cardiac capacity of heart, demonstrated by improvement in VO_2max. Also improved Duke’s treadmill score.

Metrics

Metrics Loading ...

References

Sane R, Manohar P, Mandole R, Amin G, Ghadigaokar P. Role of Ischemia Reversal Program to reduce myocardial ischemia studied with cardiac stress testing: An observational study. Eur J Pharmaceut Med Res. 2021;8(12):441-7.

Sane R, Manohar P, Mandole R, Amin G, Ghadigaokar P. Role of Ayurveda based non-invasive intervention in management of ischemic heart disease patient of diabetes. Int J Res Med Sci. 2022;10(1):196-21.

Nodeland M, Klevjer M, Sæther J, Giskeødegård G, Bathen TF, Wisløff U, et al. Atherogenic lipidomics profile in healthy individuals with low cardiorespiratory fitness: The HUNT3 fitness study. Atherosclerosis. 2022;343:51-57.

Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, et al. Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation. 2002;106(6):666-71.

Sane R, Sugwekar V, Nadapude A, Hande A, Depe G, Mandole R. Study of efficacy of ischemia reversal program (IRP) in ischemic heart disease (IHD) patients with VO2max and Duke’s treadmill score. Int J Basic Clin Pharmacol. 2018;7(8):1642-7.

Sane R, Wadekar A, Shinde K, Furia H, Upadhyaya P, Mandole R. Understanding the role of Ayurveda based Ischemia Reversal Program and low carbohydrate diet in reduction of risk of heart disease. Asian J Cardiol Res. 2019;2(1):1-8.

Rohit S, Jagdish H, Chadrakant C, Sujit N, Rahul M. Ischemia Reversal Therapy as an add-on therapy for ischemic heart disease: A pilot study based on SPECT myocardial perfusion imaging. J Cardiovascular Dis Diagnosis. 2020;8(3):100397.

Sane R, Gond B, Raje G, Walzade K, Badre A, Mandole R. Ischemia Reversal Program (IRP) in patients suffering from ischemic heart disease (IHD) with known history of hypertension: A retrospective study. J Ayurveda Med Sci. 2018;3(2):377-83.

Rohit S, Rahul M, Dawkhar S, Amin G, Ghadigaokar P. Impact of change in maximum aerobic capacity in patients with coronary artery disease: 36 months follow up. J Cardiovascular Dis Diagnosis. 2020;8(2):100398.

Sane R. Pilot open label single arm efficacy study of ischemia reversal program as add-on therapy to conventional treatment in patients with stable ischemic heart disease. J Hear Health. 2016;2(3):1-5.